@FierceBiotech: Special Report: 5 emerging eClinical firms to watch. Report | Follow @FierceBiotech
@JohnCFierce: WSJ reports insider trading probe on SAC Capital and the MedImmune acquisition. Article | Follow @JohnCFierce
> Generex has licensed its RapidMist buccal (through the cheek) drug-delivery product to Sunnyvale, CA-based Amarantus BioSciences for $10 million. Story
> Evotec bought up Galapagos NV's South San Francisco-based Compound Focus, a compound management business, for 12.5 million euros. Evotec release
> The CRO PPD has won a $45.5 million, five-year contract to handle clinical trial services for the U.S. Army. PPD release
> AstraZeneca has won Canadian approval for its blockbuster heart drug Brilinta as it continues to jockey for a U.S. OK. Article
> Alexion Pharmaceuticals has won a priority review for Soliris-designed to treat a rare genetic disease--from the FDA. Item
> The US Army Medical Research and Material Command has awarded AcelRx a $5.6 million grant to support the development of a new product candidate, ARX-04, a sublingual product for moderate-to-severe acute pain. Release
> Germany's MediGene AG and The Johns Hopkins University agreed to collaborate in the field of AAVLP vaccine technology. Release
Pharma News
@FiercePharma: France to stop paying for Pfizer's Champix. News | Follow @FiercePharma
> Novartis scouts bolt-on deals of up to $3B. Report
> Novo plots China growth to protect market share. Article
> Pfizer, Teva settle long-running Neurontin fight. Story
Drug Delivery News
> MAP Pharma files NDA for orally inhaled migraine treatment. Item
> Fluorescent carbon nanotubes light the way for drug-delivery researchers. Story
> Generex licenses buccal delivery to Amarantus for $10M. Report
> Why we love and hate the blood-brain barrier. Piece
> 'Theragnostic' nanoparticle detects and treats tumors. Article
> Packaging RNA for long-lasting, nontoxic delivery. Item
Medical Device News
> Boston Sci recalls imaging catheters. News
> Shuren to appear before House panel this week. Story
> Neoprobe sells gamma detection biz to Devicor. Item
> Advance Medical raises $6M in Series A. Article
And Finally... After reviewing the literature the World Health Organization reports that cell phones just may trigger brain cancer. Report